Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL817P is a processed pseudogene corresponding to the 7SL RNA, a non-coding RNA that forms part of the signal recognition particle (SRP), which is involved in directing proteins to the endoplasmic reticulum in cells[1]. Unlike its functional parent 7SL RNA, RN7SL817P is nonfunctional; it does not produce a mature RNA or protein product and is considered genetically inert[6][8]. Pseudogenes like RN7SL817P typically arise through reverse transcription and integration of RNA sequences back into the genome, resulting in truncated, mutated, or non-expressed genomic loci[3][8]. Though a handful of pseudogenes have regulatory or disease roles, there is no literature supporting a specific biological or clinical role for RN7SL817P.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 817, pseudogene (RN7SL817P).